FOXC2 activators, as a chemical class, encompass a range of compounds that can indirectly influence the activity of Forkhead Box C2 (FOXC2), a transcription factor with critical roles in developmental processes, cell migration, angiogenesis, and lymphangiogenesis. The regulation of FOXC2 is multifaceted, involving various signaling pathways and cellular mechanisms. Thus, the indirect modulation of FOXC2 through these chemicals provides an approach to influence its activity in the context of these biological processes.
The chemicals listed target different signaling pathways and cellular processes interconnected with FOXC2 functions. For instance, Wnt pathway agonists, TGF-β1, and FGF-2 can indirectly modulate FOXC2 activity by influencing pathways involved in cell differentiation, migration, and angiogenesis. VEGF, a crucial factor in angiogenesis, can impact FOXC2 indirectly by modulating endothelial cell function. Retinoic Acid and BMP4 target developmental and differentiation processes where FOXC2 plays a significant role. Further, the use of LY294002 and Rapamycin, targeting the PI3K/AKT/mTOR pathway, demonstrates the complex nature of cellular signaling networks and their influence on FOXC2 activity. Forskolin, by elevating cAMP levels, can indirectly affect various signaling pathways associated with FOXC2. The DNA methyltransferase inhibitor 5-Azacytidine highlights the role of epigenetic modifications in potentially regulating FOXC2 expression. Additionally, DAPT, a gamma-secretase inhibitor, can influence FOXC2 indirectly by modulating Notch signaling, a pathway known for its role in cell differentiation and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-β1, a cytokine, might influence FOXC2 indirectly by modulating cellular processes such as migration and angiogenesis, where FOXC2 plays a role. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could potentially modulate FOXC2 activity indirectly through its role in cell differentiation and development, processes where FOXC2 is implicated. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, might indirectly affect FOXC2 by influencing the PI3K/AKT pathway, which is involved in various cellular processes linked to FOXC2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, could indirectly modulate FOXC2 activity by altering cellular growth and metabolism, potentially affecting FOXC2-regulated processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an activator of adenylyl cyclase, might influence FOXC2 indirectly by elevating cAMP levels, which can impact various signaling pathways associated with FOXC2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, may indirectly impact FOXC2 activity by altering the epigenetic landscape, potentially affecting FOXC2 expression. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT, a gamma-secretase inhibitor, could influence FOXC2 indirectly by modulating Notch signaling, which is implicated in cell differentiation and development. | ||||||